These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6166827)

  • 1. [Which first-choice anti-arrhythmia agent would you use in ventricular extrasystoles following myocardial infarct?].
    Med Welt; 1981 Jun; 32(24):979-80. PubMed ID: 6166827
    [No Abstract]   [Full Text] [Related]  

  • 2. [The production of tachycardiac arrhythmia through extrasystoles. Mechanism and therapy].
    Büchner M; Effert S
    Dtsch Med Wochenschr; 1967 Nov; 92(46):2097-102. PubMed ID: 4169359
    [No Abstract]   [Full Text] [Related]  

  • 3. [Postinfarct ventricular extrasystole and the use of anti-arrhythmic drugs: a danger anticipated by electrophysiologists].
    Farré J; Brugada P
    Rev Esp Cardiol; 1989 Oct; 42(8):498-500. PubMed ID: 2481326
    [No Abstract]   [Full Text] [Related]  

  • 4. [How should ventricular arrhythmia following myocardial infarction be managed?].
    Cananau SA; Jornod JC; Uebersax R
    Rev Med Suisse Romande; 1990 Sep; 110(9):711-7. PubMed ID: 1700461
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of tetrodotoxin and ethmozine on arrhythmias of a dog heart isolated in the late stage of experimental myocardial infarct].
    Rozenshtraukh LV; Aniukhovskiĭ EP; Beloshapko GG; Dremin SA
    Biull Eksp Biol Med; 1980 Oct; 90(10):446-8. PubMed ID: 6159013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The pharmacodynamics of the new anti-arrhythmia preparation bonnecor in patients with extrasystoles].
    Ol'binskaia LI; Rybakov MA; Sizova ZhM
    Farmakol Toksikol; 1990; 53(3):63-4. PubMed ID: 1696910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [When should ventricular extrasystole be treated?].
    Kappenberger L
    Schweiz Med Wochenschr; 1987 Feb; 117(7):239-42. PubMed ID: 2436289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical trial of propafenone (rytmonorm) in arrhythmia of patients with ischemic heart disease)].
    Dobrotvorskaia TE; Koroleva ON; Gordina OV; Marakanova AV
    Klin Med (Mosk); 1996; 74(3):51-3. PubMed ID: 8926706
    [No Abstract]   [Full Text] [Related]  

  • 9. Ventricular premature complexes.
    Grover AK; Garg KC
    J Assoc Physicians India; 1989 Dec; 37(12):783-6. PubMed ID: 2484002
    [No Abstract]   [Full Text] [Related]  

  • 10. [Premature ventricular contraction].
    Ajiki K; Sugimoto T
    Nihon Rinsho; 1991 Nov; 49(11):2559-63. PubMed ID: 1722827
    [No Abstract]   [Full Text] [Related]  

  • 11. [Experience using ethacizine in myocardial infarct patients].
    Kukes VG; Ponomarenko EL; Starodubtsev AK
    Kardiologiia; 1987 May; 27(5):97-8. PubMed ID: 2443746
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of prophylactic antiarrhythmic treatment on the incidence of ventricular arrhythmias in the postinfarction period (author's transl)].
    Wolf R; Sinn R; Guillen R
    Z Kardiol; 1982 Jan; 71(1):26-30. PubMed ID: 6175118
    [No Abstract]   [Full Text] [Related]  

  • 13. [Limits of quantitative evaluation methods].
    Coumel P; Leclercq JF; Attuel P
    Arch Mal Coeur Vaiss; 1981 Dec; 74 Spec No():103-12. PubMed ID: 6176205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of premature ventricular contractions.
    Kessler KM; Chakko CS; Myerburg RJ
    Heart Dis Stroke; 1992; 1(5):275-80. PubMed ID: 1285343
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapeutic considerations in the treatment of common cardiac arrhythmias.
    Hart NJ
    Cardiovasc Clin; 1981; 12(2):107-15. PubMed ID: 6178507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Choice of a class I intravenous anti-arrhythmic drug in severe ventricular arrhythmias].
    Bernard R; Walter M; Renard M
    Ann Cardiol Angeiol (Paris); 1986 Dec; 35(10):647-52. PubMed ID: 2435202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of chronic ventricular extrasystole with propafenone (Rhythmonorm)].
    Dimitrov D
    Vutr Boles; 1984; 23(4):65-9. PubMed ID: 6209861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacodynamics and pharmacokinetics of loracainide, a new anti-arrhythmia agent].
    Meinertz T; Kasper W; Kersting F; Just H; Jähnchen E
    Verh Dtsch Ges Inn Med; 1978; (84):1477-9. PubMed ID: 84447
    [No Abstract]   [Full Text] [Related]  

  • 19. Does treatment of ventricular premature beats prevent sudden cardiac death?
    Whitlock RR
    J Med Assoc Ga; 1983 Dec; 72(12):859-61. PubMed ID: 6198415
    [No Abstract]   [Full Text] [Related]  

  • 20. [The treatment of ventricular extrasystoles in nonhospitalized patients (author's transl)].
    Cabasson J
    Ther Umsch; 1976 Feb; 33(2):100-4. PubMed ID: 60790
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.